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Abstract	  
Introduction:	  West	  Nile	  virus	  (WNV)	  is	  a	  mosquito-­‐borne	  flavivirus	  that	  was	  first	  reported	  in	  
North	  America	  in	  1999.	  	  Human	  infections	  with	  West	  Nile	  are	  often	  mild	  or	  asymptomatic,	  but	  
some	  infections	  progress	  to	  life-­‐threatening	  encephalitis.	  	  The	  Connecticut	  Agricultural	  
Experiment	  Station	  performs	  viral	  cell	  culture	  screening	  on	  mosquito	  pools	  collected	  
throughout	  the	  state	  each	  summer	  to	  detect	  viruses	  circulating	  in	  mosquito	  populations.	  Three	  
different	  real-­‐time	  RT-­‐PCR	  assays	  are	  used	  to	  identify	  WNV	  in	  positive	  cell	  cultures.	  Many	  
surveillance	  programs	  do	  not	  use	  cell	  culture	  and	  only	  use	  real-­‐time	  PCR	  to	  screen	  pools.	  
Although	  this	  can	  provide	  for	  faster	  analyses,	  some	  positive	  pools	  may	  be	  missed	  if	  mutations	  
or	  other	  factors	  cause	  the	  PCR	  reaction	  to	  fail.	  Objectives:	  	  My	  goal	  was	  to	  evaluate	  the	  
performance	  of	  three	  primer/probe	  sets	  in	  comparison	  to	  cell	  culture	  to	  evaluate	  the	  feasibility	  
of	  direct	  PCR	  analysis	  for	  surveillance.	  Methods:	  RNA	  was	  extracted	  from	  90	  WNV	  positive	  
mosquito	  pools	  and	  90	  controls	  from	  the	  2013	  surveillance	  season.	  	  Real-­‐time	  RT-­‐PCR	  was	  
performed	  once	  on	  all	  samples	  for	  each	  primer	  and	  probe	  set.	  	  Pools	  known	  to	  be	  positive	  in	  
cell	  culture	  that	  failed	  to	  amplify	  were	  sequenced	  and	  aligned	  with	  primer	  and	  probe	  sequences	  
to	  identify	  any	  mutations	  in	  the	  primer	  or	  probe	  binding	  regions.	  	  Results:	  Of	  the	  three	  assays,	  
the	  Tang,	  et	  al.	  series	  published	  in	  2006	  had	  the	  highest	  sensitivity	  and	  specificity.	  	  Only	  one	  
strain	  that	  failed	  to	  amplify	  had	  mutations	  in	  the	  critical	  primer/probe	  binding	  regions,	  so	  most	  
false	  negatives	  are	  likely	  due	  to	  other	  factors.	  Conclusion:	  The	  three	  assays	  performed	  well,	  
with	  one	  set	  performing	  better	  than	  the	  other	  two.	  	  Surveillance	  using	  only	  one	  real-­‐time	  RT-­‐
PCR	  assay	  to	  test	  samples	  should	  use	  the	  assay	  designed	  by	  Tang,	  et	  al	  (2006).	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Introduction	  
Objectives	  
West	  Nile	  virus	  (WNV)	  is	  a	  mosquito-­‐borne	  flavivirus	  capable	  of	  causing	  severe	  neuroinvasive	  
disease	  in	  humans.	  	  Surveillance	  systems	  throughout	  the	  United	  States	  and	  Europe	  use	  cell	  
culture	  and/or	  real-­‐time	  reverse	  transcriptase	  polymerase	  chain	  reaction	  (RT-­‐PCR)	  to	  identify	  
virus	  in	  collected	  mosquitoes1,2,3,4.	  While	  cell	  culture	  is	  robust	  and	  considered	  the	  “gold	  
standard”,	  PCR	  assays	  are	  faster	  and	  easier	  to	  use	  on	  a	  large	  scale.	  My	  objective	  was	  to	  
evaluate	  three	  commonly	  used	  TaqMan	  real-­‐time	  RT-­‐PCR	  primer	  series	  against	  the	  “gold	  
standard”	  of	  viral	  cell	  culture.	  	  Comparison	  of	  the	  two	  can	  identify	  strengths	  and	  weaknesses	  of	  
PCR-­‐based	  detection,	  and	  these	  results	  facilitate	  selection	  of	  the	  most	  appropriate	  detection	  
method.	  
Background	  
West	  Nile	  virus	  (WNV)	  is	  a	  flavivirus	  in	  the	  Japanese	  encephalitis	  serotype	  group	  of	  the	  genus	  
Flavivirus.	  As	  with	  all	  flaviviruses,	  WNV	  has	  a	  single	  strand,	  positive	  sense	  genome	  
approximately	  11kb	  long	  that	  contains	  a	  single	  open	  reading	  frame	  with	  5’-­‐	  and	  3’-­‐untranslated	  
regions	  (UTRs).	  	  The	  genome	  codes	  for	  four	  structural	  proteins	  and	  seven	  non-­‐structural	  
proteins	  that	  are	  translated	  as	  a	  single	  polypeptide.	  While	  the	  UTRs	  do	  not	  code	  for	  proteins,	  
these	  sequences	  are	  highly	  conserved,	  and	  interaction	  between	  secondary	  structures	  in	  these	  
regions	  are	  critical	  for	  genome	  cyclization.	  Cyclization	  of	  the	  genome	  is	  required	  for	  the	  
function	  of	  the	  flavivirus	  RNA-­‐dependent	  RNA	  polymerase	  (RdRp),	  and	  certain	  mutations	  in	  
these	  un-­‐translated	  regions	  prevent	  transcription	  of	  viral	  RNA5.	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WNV	  has	  a	  worldwide	  geographic	  distribution	  and	  has	  been	  isolated	  on	  all	  continents	  except	  
Antarctica.	  	  There	  are	  multiple	  diverging	  lineages	  with	  lineage	  1	  being	  the	  most	  widespread	  and	  
virulent	  and	  the	  lineage	  responsible	  for	  the	  most	  human	  outbreaks.	  	  The	  virus	  was	  first	  
identified	  in	  1937	  in	  a	  sample	  from	  a	  woman	  in	  the	  West	  Nile	  region	  of	  Uganda6.	  	  Outbreaks	  
occurred	  throughout	  Africa,	  Europe,	  Asia,	  and	  Australia	  starting	  in	  the	  1950s,	  but	  the	  Western	  
hemisphere	  was	  free	  of	  WNV	  until	  very	  recently2.	  WNV	  was	  first	  detected	  in	  the	  Western	  
hemisphere	  in	  New	  York	  City	  in	  1999,	  with	  the	  virus	  isolated	  from	  birds	  and	  mosquitoes7.	  	  The	  
initial	  strain	  NY99	  was	  closely	  related	  to	  a	  sample	  isolated	  in	  Israel	  in	  1998,	  and	  it	  has	  never	  
been	  determined	  whether	  the	  virus	  was	  introduced	  by	  an	  infected	  human	  or	  an	  infected	  
mosquito6.	  	  By	  2004,	  the	  virus	  had	  been	  identified	  in	  all	  48	  contiguous	  states,	  with	  two	  new	  
strains	  WN02	  and	  WN03	  replacing	  the	  original	  NY99	  strain8,9.	  	  
Culex	  species	  mosquitoes	  are	  the	  primary	  vector	  for	  WNV,	  and	  the	  primary	  reservoir	  and	  
amplifying	  hosts	  are	  passerine	  birds.	  	  Humans	  and	  other	  mammals	  are	  incidental	  hosts	  that	  do	  
not	  develop	  sufficient	  viral	  titers	  to	  re-­‐infect	  mosquitoes.	  Though	  most	  humans	  infected	  have	  
an	  asymptomatic	  infection,	  20%	  of	  infected	  individuals	  develop	  West	  Nile	  Fever,	  a	  short,	  mild	  
illness,	  and	  <1%	  develop	  potentially	  fatal	  neuroinvasive	  disease10.	  	  	  
There	  are	  multiple	  ways	  to	  screen	  mosquitoes	  for	  WNV	  infection.	  	  Cell	  culture	  is	  used	  to	  screen	  
for	  the	  presence	  of	  cytopathic	  effect	  (CPE),	  a	  particular	  type	  of	  cell	  death	  that	  is	  a	  marker	  of	  
viral	  infection.	  Collected	  mosquitoes	  are	  sorted	  by	  sex	  and	  species,	  and	  pools	  of	  up	  to	  50	  
mosquitoes	  per	  species	  per	  site	  are	  assembled.	  	  These	  mosquitoes	  are	  ground	  and	  inoculated	  
into	  Vero	  cell	  cultures.	  	  Cultures	  are	  checked	  days	  3-­‐7	  post-­‐inoculation	  for	  signs	  of	  CPE.	  	  After	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identifying	  potentially	  positive	  cultures,	  molecular	  assays	  such	  as	  real-­‐time	  and	  conventional	  
RT-­‐PCR	  are	  used	  to	  identify	  the	  virus	  present.	  This	  process	  requires	  maintaining	  a	  cold	  chain	  
and	  biosafety	  level	  3	  containment	  to	  grow	  virus	  in	  cell	  culture,	  making	  cell	  culture	  logistically	  
challenging11.	  	  The	  development	  of	  real-­‐time	  reverse	  transcription	  polymerase	  chain	  reaction	  
(RT-­‐PCR)	  assays	  to	  detect	  WNV	  has	  allowed	  for	  rapid	  identification	  of	  WNV	  RNA	  in	  birds,	  
mosquitoes,	  humans,	  and	  other	  mammals2,4.	  	  These	  real-­‐time	  RT-­‐PCR	  reactions	  are	  often	  used	  
independently	  of	  cell	  culture	  by	  surveillance	  programs	  to	  test	  mosquitoes	  of	  interest	  (Culex	  
species,	  primarily).	  	  However,	  PCR	  and	  other	  molecular	  assays	  may	  fail	  to	  detect	  the	  RNA	  of	  
viruses	  that	  contain	  mutations	  in	  the	  primer	  and/or	  probe	  binding	  regions,	  leading	  to	  false	  
negative	  results12.	  Cell	  culture	  is	  a	  robust	  and	  accurate	  method	  to	  determine	  the	  presence	  of	  
virus	  in	  pools	  because	  a	  positive	  cell	  culture	  can	  drive	  additional	  testing	  if	  the	  first	  primer	  set	  
does	  not	  give	  a	  positive	  result.	  	  This	  subsequent	  PCR	  testing	  can	  potentially	  identify	  strains	  
carrying	  mutations	  that	  interfered	  with	  the	  first	  test.	  	  Antigen-­‐detecting	  tests	  like	  VecTest	  can	  
also	  be	  used	  for	  West	  Nile	  virus	  surveillance,	  though	  they	  are	  more	  commonly	  used	  to	  test	  for	  
the	  presence	  of	  virus	  in	  dead	  birds.	  	  VecTest	  has	  also	  been	  shown	  to	  have	  a	  lower	  sensitivity	  
than	  RNA-­‐detecting	  tests	  like	  PCR13.	  	  As	  the	  geographic	  distribution	  of	  WNV	  spreads	  and	  
overlaps	  with	  other	  flaviviruses,	  the	  focus	  is	  beginning	  to	  shift	  toward	  the	  development	  of	  
multiplex	  assays	  capable	  of	  identifying	  multiple	  WNV	  lineages4,14,15	  and	  additional,	  closely	  
related	  ,viruses	  in	  a	  single	  test16,17,18.	  
Surveillance	  programs	  to	  detect	  WNV	  in	  mosquitoes	  and	  humans	  were	  established	  in	  several	  
European	  countries	  in	  the	  late	  1990s	  and	  early	  2000s1.	  	  Many	  programs	  focus	  on	  the	  
identification	  of	  WNV	  in	  mosquitoes	  because	  the	  number	  of	  positive	  mosquitoes	  in	  an	  area	  is	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predictive	  of	  the	  risk	  of	  human	  disease,	  but	  collection	  and	  testing	  of	  dead	  birds	  is	  also	  a	  
component	  of	  many	  programs19.	  	  When	  WNV	  emerged	  in	  New	  York	  in	  1999,	  the	  state	  of	  
Connecticut	  expanded	  its	  mosquito	  trapping	  program,	  then	  focused	  on	  identifying	  mosquitoes	  
infected	  with	  Eastern	  Equine	  Encephalitis	  Virus,	  to	  screen	  mosquitoes	  in	  lower	  Fairfield	  and	  
New	  Haven	  counties	  for	  WNV.	  	  WNV	  was	  successfully	  isolated	  in	  mosquitoes	  by	  the	  Connecticut	  
program	  in	  1999	  using	  cell	  culture	  and	  detected	  by	  conventional	  RT-­‐PCR7.	  New	  York	  began	  its	  
own	  screening	  program	  in	  the	  summer	  of	  2000	  using	  the	  two	  real-­‐time	  RT-­‐PCR	  assays	  
developed	  and	  published	  by	  Lanciotti	  et	  al	  in	  200020.	  	  Since	  then,	  the	  Centers	  for	  Disease	  
Control	  and	  Prevention	  (CDC)	  established	  agreements	  with	  all	  fifty	  states	  under	  the	  
Epidemiology	  Laboratory	  Capacity.	  This	  provided	  funding	  for	  detection	  and	  response	  to	  WNV	  
and	  also	  created	  ArboNET,	  a	  national	  surveillance	  platform.	  	  All	  states	  established	  surveillance	  
and	  control	  programs	  by	  2005,	  but	  funding	  has	  declined	  substantially	  since	  then.	  	  In	  2012,	  the	  
CDC	  identified	  45	  control	  jurisdictions	  that	  continued	  to	  maintain	  mosquito	  surveillance	  
capacity,	  though	  70%	  of	  these	  sites	  were	  decreasing	  trapping	  and	  testing	  of	  mosquitoes.	  
Currently,	  there	  are	  concerns	  regarding	  whether	  the	  United	  States	  can	  continue	  enough	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Research	  Design	  
Virus	  Strains	  
All	  WNV	  strains	  were	  isolated	  and	  identified	  by	  the	  Connecticut	  Agricultural	  Experiment	  Station	  
in	  mosquito	  pools	  during	  the	  2013	  surveillance	  season	  using	  the	  methods	  described	  in	  
Armstrong	  et	  al,	  2011.	  	  	  
Real-­‐time	  PCR	  
RNA	  was	  isolated	  from	  frozen	  mosquito	  pools	  for	  use	  in	  real-­‐time	  RT-­‐PCR	  analysis	  using	  the	  
QIAmp	  Viral	  RNA	  Mini	  Kit	  (Qiagen,	  Valencia,	  CA).	  	  RNA	  was	  also	  isolated	  from	  an	  equal	  number	  
of	  negative	  samples	  matched	  by	  species	  and	  time	  of	  collection	  to	  serve	  as	  controls.	  
Amplification	  and	  data	  collection	  were	  performed	  using	  the	  BioRad	  MyiQ2	  real-­‐time	  
polymerase	  chain	  reaction	  (PCR)	  detection	  system	  on	  25µl	  TaqMan	  reactions	  for	  50	  cycles.	  	  
Each	  25μl	  reaction	  contained	  8.8μl	  RNAse-­‐free	  water,	  12.5μl	  TaqMan	  ready-­‐mix,	  100μM	  of	  
each	  primer,	  33μM	  probe,	  and	  0.5μl	  of	  PE	  kit	  enzyme.	  	  Analysis	  of	  real-­‐time	  RT-­‐PCR	  results	  was	  
performed	  using	  BioRad	  iQ5	  software.	  	  Cycles	  5-­‐10	  were	  used	  for	  obtaining	  background	  
fluorescence,	  and	  the	  threshold	  was	  set	  at	  300	  relative	  fluorescence	  units	  (RFU).	  	  Samples	  were	  
considered	  positive	  if	  the	  cycle	  threshold	  (Ct)	  value	  was	  less	  than	  37.	  	  Analyses	  were	  also	  
performed	  for	  Ct	  cutoffs	  of	  40	  or	  42,	  as	  these	  are	  sometimes	  used	  as	  described	  in	  the	  
literature12.	  Calculation	  of	  sensitivity,	  specificity,	  Cohen’s	  kappa	  statistic,	  and	  positive	  and	  
negative	  predictive	  values	  was	  performed	  in	  Microsoft	  Excel	  for	  Mac	  2011	  (Microsoft,	  
Redmond,	  WA,	  USA).	  	  Sensitivity	  and	  specificity	  provide	  important	  insights	  into	  how	  well	  a	  test	  
can	  discriminate	  between	  positive	  and	  negative	  samples,	  and	  predictive	  values	  evaluate	  the	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reliability	  of	  positive	  and	  negative	  test	  results.	  	  Cohen’s	  kappa	  statistic	  provides	  some	  
information	  regarding	  the	  agreement	  between	  two	  tests.	  	  
	   Sequence	  5’	  to	  3’	  
WNV	  10668	  series	   	  
WNV	  10668	   CAGACCACGCTACGGCG	  
WNV	  11770	   CTAGGGCCGCGTGGG	  
WNV	  10692	   [6~FAM]TCTGCGGAGAGTGCAGTCTGCGAT[TAMRA~6~FAM]	  
WNV	  1160	  series	   	  
WNV	  1160	   TCAGCGATCTCTCCACCAAAG	  
WNV	  1229C	   GGGTCAGCACGTTTGTCATTG	  
WNV	  1186	   [6~FAM]TGCCCGACCATGGGAGAAGCTC[TAMRA~6~FAM]	  
WNV	  10533	  series	   	  
WNV	  10533	   AAGTTGAGTAGACGGTGCTG	  
WNV	  10625	   AGACGGTTCTGAGGGCTTAC	  
WNV	  10560	   [6~FAM]CTCAACCCCAGGAGGACTGG[BHQ1a~6~FAM]	  
Table	  1:	  Primers	  and	  probes	  for	  TaqMan	  WNV	  assays	  
	  
Sequencing	  
Samples	  positive	  for	  WNV	  in	  vero	  cell	  culture	  and	  negative	  by	  one	  or	  more	  real-­‐time	  PCR	  
reactions	  were	  sequenced	  to	  determine	  whether	  mutations	  were	  present	  in	  the	  primer	  and/or	  
probe	  binding	  regions.	  This	  information	  provides	  important	  guidance	  on	  potential	  reasons	  for	  
real-­‐time	  RT-­‐PCR	  failure	  and	  whether	  accumulation	  of	  mutations	  is	  a	  problem	  that	  may	  be	  
impacting	  results	  in	  surveillance	  settings.	  RNA	  was	  isolated	  from	  frozen	  vero	  cell	  culture	  using	  
the	  QIAmp	  Viral	  RNA	  Mini	  Kit	  (Qiagen,	  Valencia,	  CA).	  	  Conventional	  RT-­‐PCR	  using	  the	  Titan	  One	  
Tube	  RT-­‐PCR	  system	  (Roche,	  Indianapolis,	  IN)	  was	  performed	  to	  amplify	  the	  region	  of	  interest,	  
either	  the	  envelope	  region	  or	  the	  3’	  un-­‐translated	  region	  (3’UTR).	  Reactions	  mixtures	  were	  25µl	  
containing	  5µl	  5X	  RT-­‐PCR	  buffer,	  2µl	  25mM/each	  dNTPs,	  1.25µl	  100mM	  DTT	  solution,	  0.5µl	  
Titan	  enzyme	  mix,	  0.25µl	  20U/µl	  RNAse	  inhibitor,	  0.5µl	  each	  20µM	  primer,	  and	  2µl	  RNA.	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Samples	  were	  amplified	  in	  a	  BioRad	  MyiQ2	  thermocycler	  for	  35	  cycles.	  Electrophoresis	  of	  the	  
PCR	  product	  was	  performed	  on	  a	  1.5%	  agarose	  gel	  stained	  with	  ethidium	  bromide	  to	  ensure	  the	  
successful	  amplification	  of	  PCR	  product,	  and	  PCR	  product	  was	  purified	  for	  sequencing	  using	  the	  
QIAquick	  PCR	  Purification	  Kit	  (Qiagen).	  	  For	  sequencing,	  18µl	  reactions	  contained	  12µl	  nuclease	  
free	  water,	  2µl	  4µM	  primer,	  and	  4µl	  template.	  	  Sequencing	  was	  performed	  by	  the	  Keck	  
Biotechnology	  Resource	  Laboratory	  at	  Yale	  University.	  	  Due	  to	  unsuccessful	  sequencing	  
reactions,	  four	  samples	  were	  re-­‐submitted	  to	  the	  Yale	  DNA	  Analysis	  Facility	  on	  Science	  Hill.	  	  
These	  10µl	  reactions	  contained	  7µl	  nuclease	  free	  water,	  1µl	  4µM	  primer,	  and	  2µl	  template.	  
Completed	  sequences	  were	  compiled	  using	  Chromas	  Pro	  (Technelysium,	  
http://technelysium.com.au/?page_id=27)	  and	  aligned	  with	  the	  NY99	  prototype	  strain	  using	  
MEGA	  4	  (Molecular	  Evolutionary	  Genetics	  Analysis,	  
http://www.megasoftware.net/mega4/mega.html).	  
	   Sequence	  5’	  to	  3’	  
3’UTR	   	  
WNV	  10367	   ACACAACTTTGGTTGAGGACAC	  
WNV	  10916c	   TTGTGGTGTTTTGTGGCACG	  
env	   	  
WNV	  1101	   GATGAATATGGAGGCGGCCA	  
WNV	  1816A	   CCGACGTCAACTTGACAGTG	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Presentation	  and	  Analysis	  of	  Findings	  
Sensitivity	  and	  Specificity	  
Three	  real-­‐time	  RT-­‐PCR	  primer	  sets	  were	  evaluated	  for	  sensitivity	  and	  specificity	  compared	  to	  
viral	  cell	  culture	  results.	  	  	  
	   	   Ct	  <	  37	   Ct	  <	  40	   Ct	  <	  42	  
10533	  series	   Sensitivity	   0.933	   0.956	   0.978	  
	   Specificity	   1.000	   1.000	   1.000	  
1160	  series	   Sensitivity	   0.900	   0.933	   0.933	  
	   Specificity	   1.000	   0.989	   0.989	  
10668	  series	   Sensitivity	   0.867	   0.933	   0.933	  
	   Specificity	   1.000	   0.989	   0.989	  
Table	  3:	  Sensitivity	  and	  specificity	  for	  all	  three	  assays	  at	  three	  Ct	  cutoff	  values	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The	  10533	  series	  was	  most	  sensitive	  for	  all	  Ct	  cutoff	  values	  and	  maintained	  100%	  specificity.	  	  
The	  1160	  series	  and	  the	  10668	  series	  had	  equivalent	  sensitivity	  and	  specificity	  at	  higher	  cutoff	  
values,	  though	  the	  1160	  series	  was	  more	  sensitive	  when	  a	  Ct	  value	  of	  37	  was	  used.	  	  	  
Predictive	  Values	  
Positive	  and	  negative	  predictive	  values	  were	  calculated	  for	  all	  three	  assays.	  During	  the	  2013	  
season,	  the	  CAES	  tested	  a	  total	  of	  13,601	  mosquito	  pools	  of	  which	  90	  were	  positive	  for	  WNV.	  	  
The	  majority	  of	  virus-­‐positive	  mosquito	  pools	  (n=88)	  were	  from	  four	  mosquito	  species:	  Culex	  
pipiens,	  Cx.	  restuans,	  Cx.	  salinarius,	  and	  Culiseta	  melanura.	  	  The	  number	  of	  pools	  of	  these	  
species	  tested	  in	  2013	  was	  3,758.	  	  Both	  values	  for	  prevalence	  (0.7%	  of	  all	  mosquitoes	  and	  2.2%	  
of	  selected	  species)	  were	  used	  to	  calculate	  positive	  and	  negative	  predictive	  values	  for	  low	  and	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A.	  
Prevalence	  0.7%	   	   Ct	  <	  37	   Ct	  <	  40	   Ct	  <	  42	  
10533	  series	   PPV	   1.0000	   1.0000	   1.000	  
	   NPV	   0.9995	   0.9997	   0.9998	  
1160	  series	   PPV	   1.0000	   0.3610	   0.3610	  
	   NPV	   0.9993	   0.9995	   0.9995	  
10668	  series	   PPV	   1.0000	   0.3610	   0.3610	  




	   Ct<37	   Ct<40	   Ct<42	  
10533	  series	   PPV	   1.0000	   1.0000	   1.0000	  
	   NPV	   0.9983	   0.9969	   0.9994	  
1160	  series	   PPV	   1.0000	   0.6754	   0.6754	  
	   NPV	   0.9975	   0.9983	   0.9983	  
10668	  series	   PPV	   1.0000	   0.6754	   0.6754	  
	   NPV	   1.0000	   0.6754	   0.6754	  
Table	  4:	  Positive	  and	  negative	  predictive	  values	  for	  each	  assay	  at	  three	  different	  Ct	  cutoffs.	  	  A:	  
Predictive	  values	  for	  surveillance	  that	  includes	  testing	  all	  mosquitoes	  tested.	  B:	  Predictive	  
values	  for	  surveillance	  that	  only	  tests	  specific	  mosquito	  species	  of	  interest.	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A	   B	  
	   	  
C	   D	  
	   	  
Figure	  2:	  A:	  Negative	  predictive	  values	  for	  low	  prevalence	  testing	  B:	  Negative	  predictive	  
values	  for	  high	  prevalence	  testing	  C:	  Positive	  predictive	  values	  for	  low	  prevalence	  testing	  D:	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Cohen’s	  kappa	  Statistic	  
In	  order	  to	  assess	  agreement	  between	  cell	  culture	  methods	  and	  real-­‐time	  RT-­‐PCR	  assays,	  
Cohen’s	  kappa	  statistic	  was	  used.	  	  Generally,	  values	  close	  to	  1	  indicate	  very	  good	  agreement	  
between	  two	  tests21.	  	  All	  combinations	  of	  assay	  and	  Ct	  cutoff	  had	  very	  high	  kappa	  statistics	  
(excellent	  agreement),	  indicating	  a	  strong	  concordance	  between	  the	  two	  diagnostic	  techniques.	  
Cohen’s	  kappa	  
	  
Ct	  <	  37	   Ct	  <	  40	   Ct	  <	  42	  
10533	  series	   0.93	   0.96	   0.98	  
1160	  series	   0.90	   0.92	   0.92	  
10668	  series	   0.87	   0.92	   0.92	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Sequencing	  
Sequencing	  was	  performed	  on	  all	  samples	  that	  had	  false	  negative	  results	  for	  one	  or	  more	  
primer	  sets	  to	  identify	  any	  mutations	  that	  may	  have	  impacted	  the	  performance	  of	  the	  assay.	  	  
Four	  WNV	  strains	  had	  a	  nucleotide	  substitution	  in	  primer	  or	  probe	  binding	  regions	  of	  the	  
genome.	  One	  strain	  (7643-­‐13)	  contained	  mutations	  in	  both	  the	  primer	  and	  probe	  binding	  
regions	  of	  env,	  and	  three	  strains	  (13028-­‐13,	  8656-­‐13,	  8624-­‐13)	  contained	  a	  mutation	  in	  a	  
primer	  binding	  region	  in	  the	  3’UTR.	  	  All	  other	  sequences	  were	  identical	  to	  the	  NY99	  strain	  in	  the	  
critical	  primer	  and	  probe	  binding	  regions.	  
Strain	   Mutations	  
7645-­‐13	   1170	  (C	  è	  T)	  
1191	  (G	  è	  A)	  
1227	  (C	  è	  T)	  
13028-­‐13	   10544	  (A	  è	  G)	  
8656-­‐13	   10690	  (T	  è	  C)	  
8624-­‐13	   10690	  (T	  è	  C)	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Discussion	  
West	  Nile	  virus	  has	  now	  been	  endemic	  in	  the	  United	  States	  for	  15	  years.	  	  Two	  of	  the	  three	  
commonly	  used	  primer	  sets	  assessed	  were	  designed	  in	  2000,	  shortly	  after	  the	  introduction	  of	  
WNV2.	  	  As	  an	  RNA	  virus,	  WNV	  mutates	  rapidly,	  and	  viruses	  circulating	  in	  2014	  have	  
accumulated	  mutations	  in	  the	  process	  of	  adapting	  to	  indigenous	  mosquitoes	  in	  North	  America	  
that	  may	  interfere	  with	  the	  performance	  of	  these	  primers.	  	  The	  more	  recently	  designed	  primer	  
set	  was	  designed	  using	  two	  lineage	  1	  strains	  (one	  from	  New	  York	  and	  another	  from	  Europe)	  and	  
one	  lineage	  2	  strain	  to	  specifically	  identify	  highly	  conserved	  regions	  of	  the	  genome.	  	  Lineage	  2	  is	  
primarily	  found	  in	  sub-­‐Saharan	  Africa	  but	  is	  becoming	  a	  greater	  problem	  in	  Southern	  and	  
Eastern	  Europe4.	  This	  newer	  primer	  set	  performed	  better	  than	  the	  older	  primer	  sets	  in	  terms	  of	  
both	  sensitivity	  and	  specificity	  at	  all	  three	  Ct	  cutoff	  values	  and	  retained	  higher	  positive	  and	  
negative	  predictive	  values.	  It	  also	  had	  the	  greatest	  agreement	  between	  the	  cell	  culture	  and	  
real-­‐time	  RT-­‐PCR	  methods.	  The	  sensitivity	  and	  specificity	  of	  the	  10533	  series	  when	  compared	  to	  
other	  assays	  is	  consistent	  with	  published	  literature22,23.	  
Because	  of	  the	  risk	  of	  critical	  mutations,	  use	  of	  more	  than	  one	  assay	  has	  been	  recommended	  in	  
the	  literature12.	  The	  env	  gene	  sequence	  contains	  enough	  variability	  to	  be	  used	  in	  phylogenetic	  
analyses,	  and	  geographic	  and	  temporal	  clusters	  of	  WNV	  can	  be	  identified	  by	  sequencing	  this	  
region	  of	  the	  genome24,25.	  	  The	  nucleotide	  variability	  that	  allows	  for	  effective	  phylogenetic	  
analysis	  may	  be	  indicative	  of	  high	  rates	  of	  mutation	  that	  may	  lead	  to	  point	  mutations	  in	  the	  
primer	  or	  probe	  binding	  regions.	  Point	  mutations	  in	  these	  areas	  may	  compromise	  the	  sensitivity	  
of	  the	  real-­‐time	  PCR	  assay	  targeting	  this	  region	  (1160	  series)	  and	  reduce	  accuracy	  in	  estimation	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of	  viral	  burden	  in	  areas	  under	  surveillance.	  	  Surprisingly,	  our	  sequencing	  analysis	  of	  env	  showed	  
mutations	  of	  the	  primer	  and	  probe	  binding	  regions	  in	  only	  one	  strain,	  indicating	  that	  mutations	  
were	  not	  the	  most	  common	  reason	  for	  PCR	  failure.	  	  While	  the	  3’UTR	  does	  not	  code	  for	  proteins,	  
the	  sequence	  and	  secondary	  structures	  play	  vital	  roles	  in	  cyclizing	  the	  genome	  to	  permit	  
transcription	  of	  viral	  RNA.	  	  Mutations	  in	  the	  3’UTR	  can	  attenuate	  or	  completely	  inhibit	  viral	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Conclusions	  
All	  assays	  performed	  well	  in	  comparison	  to	  cell	  culture,	  and	  mutations	  are	  not	  likely	  to	  be	  
interfering	  with	  a	  large	  number	  of	  test	  results.	  One	  real-­‐time	  RT-­‐PCR	  assay	  outperformed	  the	  
others	  in	  sensitivity,	  specificity,	  agreement	  with	  cell	  culture,	  and	  predictive	  values.	  	  For	  
surveillance	  programs	  only	  running	  one	  assay	  on	  samples,	  the	  assay	  designed	  by	  Tang	  et	  al	  
(2006)	  is	  recommended.	  	  Few	  strains	  contained	  mutations	  in	  the	  primer	  or	  probe	  binding	  
regions	  of	  the	  genome,	  so	  mutation	  was	  not	  a	  factor	  in	  most	  of	  the	  real-­‐time	  RT-­‐PCR	  false	  
negatives.	  
Limitations	  
The	  BioRad	  MyiQ2	  real-­‐time	  PCR	  system	  and	  the	  iQ5	  software	  used	  in	  the	  real-­‐time	  PCR	  
analysis	  did	  not	  give	  clean	  amplification	  curves	  on	  many	  samples	  tested,	  and	  unstable	  baselines	  
resulted	  in	  higher	  Ct	  values	  in	  some	  samples	  and	  lower	  Ct	  values	  in	  others.	  The	  number	  of	  
baseline	  cycles	  and	  the	  threshold	  were	  adjusted	  in	  an	  attempt	  to	  separate	  the	  amplified	  signals	  
(positive	  samples)	  from	  the	  linear	  signals	  (negative	  samples),	  and	  a	  baseline	  from	  cycles	  5-­‐10	  
and	  a	  threshold	  of	  300	  RFU	  was	  selected.	  	  These	  adjustments	  are	  by	  their	  very	  nature	  
subjective.	  	  Multiple	  techniques	  can	  be	  used	  to	  select	  baseline	  and	  threshold	  values,	  but	  there	  
is	  no	  one	  method	  that	  works	  best	  in	  all	  situations27.	  	  
Mosquito	  pools	  yielding	  positive	  cell	  cultures	  are	  assumed	  to	  be	  positive	  for	  virus	  and	  may	  be	  
tested	  repeatedly	  until	  an	  identification	  is	  made.	  	  However,	  it	  is	  possible	  that	  strains	  of	  WNV	  
with	  significant	  mutations	  in	  multiple	  primer	  and	  probe	  binding	  regions	  may	  have	  still	  failed	  to	  
identify	  these	  strains	  as	  WNV.	  	  Re-­‐testing	  of	  these	  samples	  using	  other	  real-­‐time	  PCR	  assays	  
	   21	  
should,	  in	  theory,	  identify	  strains	  with	  mutations	  in	  only	  one	  primer/probe	  binding	  region.	  	  
However,	  two	  of	  the	  90	  strains	  tested	  here	  were	  missed	  by	  all	  three	  primer	  sets,	  and	  the	  
prevalence	  of	  mutations	  that	  impact	  the	  sensitivity	  of	  these	  assays	  is	  likely	  underestimated.	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